|
RDX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.45046213823252E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.38737976241555E-12 |
| Normal-vs-Stage2 |
9.77670000512632E-08 |
| Normal-vs-Stage3 |
1.58966999999066E-05 |
| Normal-vs-Stage4 |
4.30249999999743E-05 |
| Stage1-vs-Stage2 |
6.594000E-01 |
| Stage1-vs-Stage3 |
3.259400E-01 |
| Stage1-vs-Stage4 |
6.676800E-01 |
| Stage2-vs-Stage3 |
7.098200E-01 |
| Stage2-vs-Stage4 |
9.131600E-01 |
| Stage3-vs-Stage4 |
8.488600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.4237946639214E-12 |
| Normal-vs-AfricanAmerican |
6.34789998343877E-09 |
| Normal-vs-Asian |
1.93371999999137E-05 |
| Caucasian-vs-AfricanAmerican |
5.103000E-01 |
| Caucasian-vs-Asian |
5.533200E-01 |
| AfricanAmerican-vs-Asian |
4.034800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62625468647093E-12 |
| Normal-vs-Female |
1.1363999996572E-07 |
| Male-vs-Female |
2.444400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.59509999653196E-08 |
| Normal-vs-Extreme_Weight |
1.6251444634463E-12 |
| Normal-vs-Obese |
9.03120001005675E-09 |
| Normal-vs-Extreme_Obese |
2.07849999999121E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.281000E-01 |
| Normal_Weight-vs-Obese |
4.658200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.444000E-01 |
| Extreme_Weight-vs-Obese |
1.661650E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.309200E-01 |
| Obese-vs-Extreme_Obese |
7.045800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.914000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.58280000217559E-09 |
| Normal-vs-Age(61-80Yrs) |
4.66293670342566E-15 |
| Normal-vs-Age(81-100Yrs) |
3.59800000000465E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.876410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.531800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.095200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.105830E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.162400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.650600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
2.16240000350254E-08 |
| Normal-VS-KIRP CIMP |
3.053800E-01 |
| Normal-VS-Unclassified PRCC |
9.52810000010018E-07 |
| Type1 PRCC-VS-Type2 PRCC |
4.332100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.208300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.902300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.424180E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.574800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.407630E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.02499963650882E-10 |
| Normal-vs-N1 |
2.276000E-03 |
| Normal-vs-N2 |
4.05510000001108E-06 |
| N0-vs-N1 |
2.235800E-01 |
| N0-vs-N2 |
2.328800E-01 |
| N1-vs-N2 |
1.554650E-01 |
|
|
